You are here

Article info

Article menu

Download PDFPDF

Editorial
To bridge or not to bridge: summary of the new evidence in endovascular stroke treatment

Authors

  • Anna Podlasek Tayside Innovation MedTech Ecosystem (TIME), University of Dundee, Dundee, UK NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK PubMed articlesGoogle scholar articles
  • Permesh Singh Dhillon NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, UK Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK PubMed articlesGoogle scholar articles
  • Waleed Butt Interventional Neuroradiology, Nottingham University Hospitals NHS Trust, Nottingham, UK Interventional Neuroradiology, University Hospitals Birmingham NHS Trust, Birmingham, UK PubMed articlesGoogle scholar articles
  • Iris Q Grunwald Tayside Innovation MedTech Ecosystem (TIME), University of Dundee, Dundee, UK PubMed articlesGoogle scholar articles
  • Timothy J England Stroke, Division of Mental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, UK Stroke, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Anna Podlasek; podlasek.a{at}gmail.com
View Full Text

Citation

Podlasek A, Dhillon PS, Butt W, et al
To bridge or not to bridge: summary of the new evidence in endovascular stroke treatment
Stroke and Vascular Neurology 2022;7:doi: 10.1136/svn-2021-001465

Publication history

  • Received December 16, 2021
  • Accepted January 20, 2022
  • First published February 1, 2022.
Online issue publication 
November 15, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.